CATEGORIES

Coronavirus

LATEST

TRENDING

EDITORS CHOICE

COVID-19 Trials: Why Are We Asking Questions We Know Answers To?

The author reviews a recent randomized clinical trial of ivermectin’s effect on COVID-19 outcomes..

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

The Covid Files: A Series Separating Pandemic Fact from Fiction

We've all just experienced a hopefully once-in-a-lifetime event, and if you survived it relatively unscathed, well done. Looking back on the Covid pandemic in...

North Texas Obgyns Need to Know About Monoclonal Antibodies for Covid-19

Obgyn physicians and women's health providers must help pregnant people find access to monoclonal antibody therapy during the early stages of a Covid-19 infection to help prevent severe disease and death.